Summers Small Cap Stock Portfolio

CORAL GABLES, FL / ACCESSWIRE / June 26, 2015 / Continued overhang from the crisis in Greece continue to weigh down the larger markets. In the larger markets, the standstill to finalize decisions has negatively affected many companies trading on the NYSE and NASDAQ. One segment not seeing any kind of consolidation has been the market that is trading penny stocks. Tens, hundreds, and even thousands of percentage points have been realized during a time of financial turmoil overseas. Despite these dealings, small and micro cap stocks have surged during the early parts of the summer months. Progressive Care, Inc. (OTC:RXMD), Enviro-Serv, Inc. (OTC:EVSV), and RXi Pharmaceuticals Corporation (NASDAQ:RXII) have also seen price as well as volume trend above average.

Progressive Care announced mid quarter results on Thursday to highlight the immense progress that the Company continues to see. Following a “banner” first quarter with $3million in revenue and above average prescription counts, Progressive announced that through its subsidiary, PharmCo, it has reached over $2.3 million in revenues for the 2-month period. PharmCo achieved $1.4 million in revenues during the month of May as a standalone period. With only a 28% increase in filled prescriptions over the same period last year, the Company grew revenues by over 30%. Shares of RXMD skyrocketed to highs nearing $0.05 up 790% from the close on Wednesday on above average volume.

“We are very proud of what we have been able to accomplish this year. We are on pace to post over $1 million per month in revenues and we believe we can improve on those results as we enter our busy season in the fall and winter,” stated Shital Parikh Mars, COO.

The Company expects to provide an update on the second quarter’s prescription and revenue figures in the second week of July 2015.

Enviro-Serv, Inc. has also made waves in the penny stock department. Following previous months of trading between $0.0001-$0.0002, shares of EVSV have managed to rally to highs of $0.0015 in recent weeks. Furthermore, speculation continues to build surrounding the next announcement that the Company comes out with. The reason for this is based on what management stated in a previous release, “The Company originally anticipated closing [the Pestmasters deal] in mid-July and due to the rapid pace that Enviro-Serv is moving, management will be closing on this agreement with the Pestmaster Franchise on or before June 30th.”

Biotech and healthcare have been the outliers within the market and have seemingly surged no matter what sociopolitical events are taking place. Most recently RXi Pharmaceuticals Corporation has seen this first hand. Earlier this month the Company announced that it received two Notices of Allowance from the United States Patent and Trademark Office (USPTO). One is on RXi’s novel, self-delivering RNAi platform (sd‑rxRNA(R)). The patent, titled “Reduced Size Self-Delivering RNAi Compounds,” covers both the composition and methods of use of RXi’s self-delivering platform. “We are pleased to receive both of these Notices of Allowance from the USPTO, which further broaden and protect the Company’s already robust patent estate.” said Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals.

Over the last month, shares of RXII have increased from lows of $0.342 to highs of $0.62 on Thursday marking a total run up of 81.3%.

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase “StockAlerts” to 63566.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.

EGM FIRM INC, which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com

SOURCE: Daily Stock Reporter

ReleaseID: 430178